NCT02094963View on ClinicalTrials.gov

Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management

PHASE4CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

July 5, 2014

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Acute Coronary SyndromeMyocardial IschemiaHeart DiseasesCardiovascular DiseasesAngina Pectoris
Interventions
DRUG

Ticagrelor

180mg loading and 90mg bid

DRUG

Clopidogrel

600mg loading and 75mg qd

Trial Locations (10)

138-736

Asan Medical Center, Seoul

Unknown

Keimyung University Dongsan Medical Center, Daegu

Chungnam National University Hospital, Daejeon

Dongguk University Gyeongju Hospital, Gyeongju

Inje University Ilsan Paik Hospital, Ilsan

Gachon University Gil Hospital, Incheon

ChonBuk National University Hospital, Jeonju

Dong-A Medical Center, Pusan

Inje University Pusan Paik Hospital, Pusan

Ulsan University Hospital, Ulsan

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER

NCT02094963 - Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management | Biotech Hunter | Biotech Hunter